



Infection in a Man, 
Greece
To the Editor: In Greece, 6 spotted 
fever group (SFG) Rickettsia species 
have been detected in ticks: Rickettsia 
conorii, R. massiliae, R. aeschlimannii, 
R. sibirica mongolitimonae, R. slovaca, 
and R. rhipicephali (1). SFG species 
present characteristic clinical signs, 
including high fever, headache, and 
maculopapular rash; an inoculation es-
char at the tick bite site is characteristic 
of some, but not all, SFG rickettsioses. 
Symptoms during the early stages of 
illness are nonspecific, and diagnosis is 
a challenge for physicians who are not 
familiar with rickettsial diseases. So 
far, 2 SFG Rickettsia species have been 
implicated in human disease in Greece: 
Mediterranean spotted fever caused 
by R. conorii (2), and lymphagitis-
associated rickettsiosis (LAR) caused 
by R. sibirica mongolitimonae (3). We 
report a rickettsiosis case in a man on 
the island of Crete, Greece caused by 
a third Rickettsia species belonging to 
the SFG, R. aeschlimannii.
During June 2010, a 70-year-old 
man residing in an agricultural area 
of eastern Crete was admitted to the 
emergency unit of General Hospital 
of Agios Nikolaos for evaluation of a 
reddish, painless papule on the ante-
rior surface of his left arm. The pap-
ule was 2 cm in diameter, and was 
surrounded by a less reddened infil-
trated area 8 cm in diameter (Figure). 
The area was without tenderness or 
pruritus. At the center of the papule, 
which was cyanotic, the presence of 
a tick was recorded, and the tick was 
removed carefully in its entirety. The 
patient was afebrile and reported no 
other symptoms. The papule had de-
veloped within few hours, although 
5 days previously, the patient had 
noticed a dark colored nodule on his 
left arm but paid no attention to it. The 
patient reported that rabbits were bred 
and goats and sheep grazed at close 
proximity to his residence.
 Serum and whole blood samples 
were drawn, and a local skin biopsy 
was performed from the center of the 
skin lesion. Laboratory tests revealed 
a high level of C-reactive protein, mi-
croscopic hematuria, and a leukocyte 
count of 6.01 × 109 cells/L. Hepatic 
enzymes alanine transaminase and as-
partate aminotransferase were within 
normal ranges. The patient was treated 
with doxycycline, 100 mg twice daily 
for 7 days; he did not develop further 
symptoms, and the skin lesion healed 
without ulceration.
All samples were sent to the Lab-
oratory of Clinical Bacteriology, Para-
sitology, Zoonoses and Geographic 
Medicine at the University of Crete 
for further testing. The tick was identi-
fied as Rhipicephalus turanicus by us-
ing standard taxonomic keys (4). IgG 
and IgM titers reactive to SFG rickett-
siae antigens were determined by an 
immunofluorescence antibody assay 
as described by the manufacturer (bio-
Mérieux, Marcy l’Etoile, France). 
Twenty days after initial assess-
ment and treatment, convalescent-
phase blood samples were drawn for 
serum and whole blood analysis. Ti-
ters against R. conorii were detected 
in both the initial samples (IgM 1/100, 
IgG 1/60) and the convalescent-phase 
samples (IgM 1/100, IgG 1/120). 
DNA was extracted from the blood 
samples, the skin biopsy, and the tick 
by using a QIAamp Tissue Kit (QIA-
GEN, Courtaboeuf, France ) and used 
as a template in previously described 
PCR assays by using primers RpCS 
877p-RpCS 1258n and Rr19070p-
Rr190602n, targeting a 381-bp portion 
of the gltA and a 532-bp portion of the 
ompA genes of Rickettsia spp. (5). 
The whole blood drawn in the hospi-
tal, the skin biopsy, and the tick were 
positive for both genes. However, 
the convalescent-phase blood sample 
was negative. 
PCR products were purified by 
using the QIAquick Spin PCR Purifi-
cation Kit (QIAGEN) and sequenced 
(Bioanalytica–Genotype, Athens, 
Greece) according to the manufactur-
er’s instructions. Sequences obtained 
shared 100% similarity to the cor-
responding fragment of the genome 






ompA: JF803906). All samples were 
cultured in human embryonic lung 
fibroblasts as described (6). After 4 
weeks, no bacteria were isolated. 
We report a human case of R. es-
chlimannii infection in Crete, Greece. 
Our finding was confirmed by molec-
ular methods. However, we were not 
able to cultivate R. aeschlimannii from 
samples collected. This result suggests 
that living microorganisms may have 
died before testing or that only DNA, 
but no living organism, was present in 
the samples. R. aeschlimannii was first 
isolated from Hyalomma marginatum 
ticks from Morocco (7). In Europe, 
R. aeschlimannii has also been found 
in ticks from Germany, Russia, Italy, 
France, Croatia, Portugal, and Spain 
(8). In Greece, R. aeschlimannii has 
been detected in H. anatolicum exca-
vatum ticks collected from sheep (1). 
The tick removed from this patient 
was Rh. turanicus, a species that has 
been reported in Spain to be infected 
with R. aeschlimannii (9). 
The first human case of R. ae-
schlimannii infection was identified 
in a patient who had fever, rash, and 
an eschar after travel in Morocco 
(10). R. aeschlimannii infections in 
humans have been previously con-
firmed in South Africa, in Algeria, 
and in Tunisia (8). To our knowledge, 
human cases of R. aeschlimannii in-
fection have not been reported in 
Europe. Our results emphasize that 
ticks should be considered as poten-
tial vectors for rickettsial infections 
in humans. We recommend that when 
one species or serotype of tick-trans-
mitted Rickettsia is identified in an 
area, physicians be informed through 
established clinical or public health 
channels of the potential pathogen, 
its manifestations, and recommended 
treatments for humans. 
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Antibodies against 
Rift Valley Fever 
Virus in Cattle,  
Mozambique
To the Editor: During the past 
2 decades, several countries in Africa 
and the Arabian Peninsula, to which 
Rift Valley fever virus (RVFV) is en-
demic, have reported outbreaks of Rift 
Valley fever in humans and livestock. 
The first evidence of RVFV in Mo-
zambique was documented as early as 
the 1960s (1). Endemicity was subse-
quently confirmed in the 1980s by a 
prevalence study that identified virus-
specific antibodies in 2% of pregnant 
women (2) and in the 1990s by sero-
surveillance in Zambezia Province, 
which showed that cattle had been 
infected with RVFV (3).
Apart from those observations, 
the RVFV situation in Mozambique 
is still poorly understood. We recently 
found an unexpectedly high level of 
RVFV activity in cattle in Namaacha 
District in Maputo Province (4), a re-
gion where there had been no recorded 
evidence of the virus since 1969 (1). 
We conducted a cross-sectional study 
in which serum samples were col-
lected throughout Maputo Province 
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